These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9105185)

  • 1. Changes in strategies for human papillomavirus genital disease.
    Apgar BS
    Am Fam Physician; 1997 Apr; 55(5):1545-6, 1548. PubMed ID: 9105185
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence of infection with carcinogenic human papillomavirus among older women.
    Sellors JW; Karwalajtys TL; Kaczorowski JA; Mahony JB; Lytwyn A; Chong S; Sparrow J; Lorincz A;
    CMAJ; 2002 Oct; 167(8):871-3. PubMed ID: 12406945
    [No Abstract]   [Full Text] [Related]  

  • 3. Human Papillomavirus DNA detection for cervical cancer screening.
    Press RD
    Mol Diagn; 2000 Sep; 5(3):245-7. PubMed ID: 11186127
    [No Abstract]   [Full Text] [Related]  

  • 4. Human papillomavirus DNA testing in community screening for diseases of the cervix uteri.
    Chan SY
    Clin Sci (Lond); 1996 Sep; 91(3):250-2. PubMed ID: 8869401
    [No Abstract]   [Full Text] [Related]  

  • 5. [The role of tumor-related papillomavirus infection of the genitals in the genesis of background pathology of the ectocervix, dysplasia and preinvasive cancer of the cervix uteri].
    Maksimov SIa; Savicheva AM; Bashmakova MA; Shaimardanova GI; Shipitsina EV; Rybina EV
    Vopr Onkol; 1999; 45(6):627-9. PubMed ID: 10703510
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical question: ask the experts.
    Julian TM; Waxman AG; Calkins JW
    J Low Genit Tract Dis; 2005 Oct; 9(4):243-4. PubMed ID: 16205198
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluating the role of HPV testing for women with equivocal Papanicolaou test findings.
    Cox JT
    JAMA; 1999 May; 281(17):1645-7. PubMed ID: 10235161
    [No Abstract]   [Full Text] [Related]  

  • 8. Serologic detection of human papillomavirus-related anogenital disease: new opportunities and challenges.
    Palefsky JM
    J Natl Cancer Inst; 1995 Mar; 87(6):401-2. PubMed ID: 7861455
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of human papillomavirus deoxyribonucleic acid assay and repeated cervical cytologic examination in the detection of cervical intraepithelial neoplasia among human immunodeficiency virus-infected women. Cervical Disease Study Group of the American Foundation for AIDS Research Community Based Clinical Trials Network.
    Cohn JA; Gagnon S; Spence MR; Harrison DD; Kluzak TR; Langenberg P; Brinson C; Stein A; Hellinger J;
    Am J Obstet Gynecol; 2001 Feb; 184(3):322-30. PubMed ID: 11228481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of human papillomavirus testing by hybrid capture in the triage of women with repeated abnormal pap smears before colposcopy referral.
    Fait G; Kupferminc MJ; Daniel Y; Geva E; Ron IG; Lessing JB; Bar-Am A
    Gynecol Oncol; 2000 Nov; 79(2):177-80. PubMed ID: 11063640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Imiquimod: a new treatment possibility in bowenoid papulosis?].
    Wigbels B; Luger T; Metze D
    Hautarzt; 2001 Feb; 52(2):128-31. PubMed ID: 11244890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Management of a low grade smear].
    Baldauf JJ; Ritter J
    Contracept Fertil Sex; 1999 Apr; 27(4):269-74. PubMed ID: 10349768
    [No Abstract]   [Full Text] [Related]  

  • 13. Does typing of human papillomavirus assist in the triage of women with repeated low-grade, cervical cytologic abnormalities?
    Fait G; Daniel Y; Kupferminc MJ; Lessing JB; Niv J; Bar-Am A
    Gynecol Oncol; 1998 Sep; 70(3):319-22. PubMed ID: 9790781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correspondence Re: M. Schiffman and A. Schatzkin, test reliability is critically important to molecular epidemiology: an example from studies of human papillomavirus infection and cervical neoplasia. Cancer Res. (suppl.), 54: 1944s-1947s, 1994.
    Bosch FX; de Sanjosé S; Muñoz N
    Cancer Res; 1994 Dec; 54(23):6288-9. PubMed ID: 7954479
    [No Abstract]   [Full Text] [Related]  

  • 15. Type-specific prevalence of human papillomavirus DNA among Jamaican colposcopy patients.
    Rattray C; Strickler HD; Escoffery C; Cranston B; Brown C; Manns A; Schiffman MH; Palefsky JM; Hanchard B; Blattner WA
    J Infect Dis; 1996 Mar; 173(3):718-21. PubMed ID: 8627038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new generation of studies of human papillomavirus DNA testing in cervical cancer screening.
    Franco EL
    J Natl Cancer Inst; 2009 Dec; 101(23):1600-1. PubMed ID: 19903806
    [No Abstract]   [Full Text] [Related]  

  • 17. Does typing of human papillomavirus assist in the triage of women with repeated low-grade, cervical cytologic abnormalities?
    Kaufman RH; Adam E
    Gynecol Oncol; 1998 Sep; 70(3):317-8. PubMed ID: 9790780
    [No Abstract]   [Full Text] [Related]  

  • 18. Imiquimod: a cytokine inducer.
    Dahl MV
    J Am Acad Dermatol; 2002 Oct; 47(4 Suppl):S205-8. PubMed ID: 12271278
    [No Abstract]   [Full Text] [Related]  

  • 19. Human papillomavirus DNA remains detectable longer than related cervical cytologic abnormalities.
    Schiffman M; Wheeler CM; Castle PE;
    J Infect Dis; 2002 Oct; 186(8):1169-72. PubMed ID: 12355370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time to consider HPV testing in cervical screening.
    Cuzick J
    Ann Oncol; 2001 Nov; 12(11):1511-4. PubMed ID: 11822748
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.